Cagrilintide (2.5mg) / GLP-1 S (2.5mg)

Product Overview:

• Cagrilintide (2.5mg) and GLP-1 S (2.5mg) are intended for use in controlled research environments to investigate their potential effects on metabolic pathways, energy balance, and appetite control mechanisms.
• These compounds are not approved for human consumption or clinical use outside of research protocols and should only be handled by qualified professionals in an appropriate setting.

Key Features:

• Research-Grade Peptides: Both Cagrilintide and GLP-1 S are peptides that are being studied for their effects on appetite regulation, satiety, and metabolic processes in preclinical and clinical research studies.
• Investigational Compound: This product is available exclusively for research purposes and has not been approved by regulatory agencies for general medical use.
• Controlled Dosage: Cagrilintide and GLP-1 S are provided in a precise 2.5mg dose to ensure consistency in research protocols.

Research Potential:

• Appetite Regulation Studies: Both Cagrilintide and GLP-1 S are under investigation for their potential to influence hunger signals and energy balance.
• Metabolic Health Research: Studies are exploring the role of these peptides in regulating insulin sensitivity, glucose metabolism, and fat metabolism.
• Weight Management: Research into how these peptides may impact body weight, fat loss, and overall metabolic function is ongoing.